Cargando…
Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients
BACKGROUND: Thromboembolic disease is a frequent cause of death during SARS CoV-2 infection. Lupus anticoagulant (LA) appears frequently during the acute phase of infection. It is not clear whether it is merely an epiphenomenon or whether it is related to the patients' outcome. METHODS: Prospec...
Autores principales: | Constans, Mireia, Santiago, Raquel, Jimenez, Lidia, Motllo, Cristina, Lopez, Rosario, Trapé, Jaume, Reverter, J. Carlos, Altes, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539822/ https://www.ncbi.nlm.nih.gov/pubmed/34743034 http://dx.doi.org/10.1016/j.thromres.2021.10.017 |
Ejemplares similares
-
Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
por: Egri, Natalia, et al.
Publicado: (2021) -
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant
por: Posch, Florian, et al.
Publicado: (2017) -
Lupus anticoagulant test persistence over time and its associations with future thrombotic events
por: Colling, Meaghan E., et al.
Publicado: (2022) -
Lupus anticoagulant and mortality in patients hospitalized for COVID-19
por: Gazzaruso, Carmine, et al.
Publicado: (2020) -
Recurrent nonbacterial thrombotic endocarditis and stroke on anticoagulation
por: Basnet, Sijan, et al.
Publicado: (2020)